2 active not recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Primary Biliary Cholangitis: new trials by email Literature Review of Primary Biliary Cholangitis trials Research Report on Primary Biliary Cholangitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis Fenofibrate, Placebo, UDCA - Primary Biliary Cholangitis | Phase 2 / Phase 3 | Active not recruiting | Han Ying | 184 | 2023-08-21 | 2026-10-29 |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis Volixibat, Placebo - Primary Biliary Cholangitis, PBC | Phase 2 | Active not recruiting | Mirum Pharmaceuticals, Inc. | 333 | 2021-09-22 | 2026-08-25 |
Liver Cirrhosis, Biliary (2) · Cholangitis (1) · Digestive System Diseases (1) · Pruritus (1)
Bile Duct Diseases (2) · Biliary Tract Diseases (2) · Cholestasis (2) · Cholestasis, Intrahepatic (2) · Fibrosis (2) · Liver Cirrhosis (2) · Liver Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Digestive System Diseases (1) · Signs and Symptoms (1) · Skin Diseases (1) · Skin Manifestations (1) · Skin and Connective Tissue Diseases (1)
Fenofibrate (1) · volixibat (1)
Han Ying (1) · Mirum Pharmaceuticals, Inc. (1)
China (2) · Argentina (1) · Belgium (1) · Brazil (1) · Canada (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)